SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (845)10/9/2001 12:06:08 PM
From: tuck  Read Replies (1) of 1784
 
Trickle thinks the hype about BDAL's recent DoD success is priced in, short term. That this sucker will sell off on earnings. Accordingly, Trickle bails on BDAL again at $20. Pullbacks to middle teens will be bought, pending fundamental changes. What a trader that's been for Trickle.

Trickle buys 300 TWTI for $6.55. Will add if it revisits the $5 range.

Suggestions for use of the cash? I'm very tempted by AFFX. One poster has worried about AFFX warning, but wouldn't it have done so by now? Another has suggested ILMN might be competitive, and I know of others, but AFFX has significant first mover advantage. Speaking of moving, now that I'm more or less settled in, I need to start digging on this stuff, unless someone qualified is kind enough to supply me with the answers before the week ends.

Thinking I'll sit on the cash till next week, and see how this Florida anthrax business develops. It seems like a field test by our enemy.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext